1
|
Selescu T, Bivoleanu RA, Iodi Carstens M, Manolache A, Caragea VM, Hutanu DE, Meerupally R, Wei ET, Carstens E, Zimmermann K, Babes A. TRPM8-dependent shaking in mammals and birds. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2023.12.27.573364. [PMID: 38234797 PMCID: PMC10793462 DOI: 10.1101/2023.12.27.573364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2024]
Abstract
Removing water from wet fur or feathers is important for thermoregulation in warm-blooded animals. The "wet dog shake" (WDS) behavior has been largely characterized in mammals but to a much lesser extent in birds. Although it is known that TRPM8 is the main molecular transducer of low temperature in mammals, it is not clear if wetness-induced shaking in furred and feathered animals is dependent on TRPM8. Here, we show that a novel TRPM8 agonist induces WDS in rodents and, importantly, in birds, similar to the shaking behavior evoked by water-spraying. Furthermore, the WDS onset depends on TRPM8, as we show in water-sprayed mice. Overall, our results provide multiple evidence for a TRPM8 dependence of WDS behaviors in all tested species. These suggest that a convergent evolution selected similar shaking behaviors to expel water from fur and feathers, with TRPM8 being involved in wetness sensing in both mammals and birds.
Collapse
|
2
|
Sanders OD, Rajagopal JA, Rajagopal L. Menthol to Induce Non-shivering Thermogenesis via TRPM8/PKA Signaling for Treatment of Obesity. J Obes Metab Syndr 2021; 30:4-11. [PMID: 33071240 PMCID: PMC8017329 DOI: 10.7570/jomes20038] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2020] [Revised: 05/25/2020] [Accepted: 06/12/2020] [Indexed: 12/25/2022] Open
Abstract
Increasing basal energy expenditure via uncoupling protein 1 (UCP1)-dependent non-shivering thermogenesis is an attractive therapeutic strategy for treatment of obesity. Transient receptor potential melastatin 8 (TRPM8) channel activation by cold and cold mimetics induces UCP1 transcription and prevents obesity in animals, but the clinical relevance of this relationship remains incompletely understood. A review of TRPM8 channel agonism for treatment of obesity focusing on menthol was undertaken. Adipocyte TRPM8 activation results in Ca2+ influx and protein kinase A (PKA) activation, which induces mitochondrial elongation, mitochondrial localization to lipid droplets, lipolysis, β-oxidation, and UCP1 expression. Ca2+-induced mitochondrial reactive oxygen species activate UCP1. In animals, TRPM8 agonism increases basal metabolic rate, non-shivering thermogenesis, oxygen consumption, exercise endurance, and fatty acid oxidation and decreases abdominal fat percentage. Menthol prevents high-fat diet-induced obesity, glucose intolerance, insulin resistance, and liver triacylglycerol accumulation. Hypothalamic TRPM8 activation releases glucagon, which activates PKA and promotes catabolism. TRPM8 polymorphisms are associated with obesity. In humans, oral menthol and other TRPM8 agonists have little effect. However, topical menthol appears to increase core body temperature and metabolic rate. A randomized clinical control trial of topical menthol in obese patients is warranted.
Collapse
Affiliation(s)
| | | | - Lekshmy Rajagopal
- Oto-Rhino-Laryngology, College of Physicians and Surgeons, Mumbai, India
| |
Collapse
|
3
|
Caudle RM, Caudle SL, Flenor ND, Rohrs EL, Neubert JK. Pharmacological Characterization of Orofacial Nociception in Female Rats Following Nitroglycerin Administration. Front Pharmacol 2020; 11:527495. [PMID: 33343340 PMCID: PMC7744726 DOI: 10.3389/fphar.2020.527495] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Accepted: 10/19/2020] [Indexed: 11/13/2022] Open
Abstract
Rodent models of human disease can be valuable for understanding the mechanisms of a disease and for identifying novel therapies. However, it is critical that these models be vetted prior to committing resources to developing novel therapeutics. Failure to confirm the model can lead to significant losses in time and resources. One model used for migraine headache is to administer nitroglycerin to rodents. Nitroglycerin is known to produce migraine-like pain in humans and is presumed to do the same in rodents. It is not known, however, if the mechanism for nitroglycerin headaches involves the same pathological processes as migraine. In the absence of known mechanisms, it becomes imperative that the model not only translates into successful clinical trials but also successfully reverse translates by demonstrating efficacy of current therapeutics. In this study female rats were given nitroglycerin and nociception was evaluated in OPADs. Estrous was not monitored. Based on the ED50 of nitroglycerin a dose of 10 mg/kg was used for experiments. Sumatriptan, caffeine, buprenorphine and morphine were administered to evaluate the reverse translatability of the model. We found that nitroglycerin did not produce mechanical allodynia in the face of the rats, which is reported to be a consequence of migraine in humans. Nitroglycerin reduced the animals’ participation in the assay. The reduced activity was verified using an assay to measure exploratory behavior. Furthermore, the effects of nitroglycerin were not reversed or prevented by agents that are effective acute therapies for migraine. Two interesting findings from this study, however, were that morphine and nitroglycerin interact to increase the rats’ tolerance of mechanical stimuli on their faces, and they work in concert to slow down the central motor pattern generator for licking on the reward bottle. These interactions suggest that nitroglycerin generated nitric oxide and mu opioid receptors interact with the same neuronal circuits in an additive manner. The interaction of nitroglycerin and morphine on sensory and motor circuits deserves additional examination. In conclusion, based on the results of this study the use of nitroglycerin at these doses in naïve female rats is not recommended as a model for migraine headaches.
Collapse
Affiliation(s)
- Robert M Caudle
- Department of Oral and Maxillofacial Surgery, University of Florida, Gainesville, FL, United States
| | - Stephanie L Caudle
- Department of Orthodontics, University of Florida, Gainesville, FL, United States
| | - Natalie D Flenor
- Department of Orthodontics, University of Florida, Gainesville, FL, United States
| | - Eric L Rohrs
- Velocity Laboratories, LLC, Alachua, FL, United States
| | - John K Neubert
- Department of Orthodontics, University of Florida, Gainesville, FL, United States
| |
Collapse
|
4
|
De Caro C, Russo R, Avagliano C, Cristiano C, Calignano A, Aramini A, Bianchini G, Allegretti M, Brandolini L. Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat. Br J Pharmacol 2018; 175:1691-1706. [PMID: 29485712 DOI: 10.1111/bph.14177] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2017] [Revised: 01/23/2018] [Accepted: 02/05/2018] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND AND PURPOSE Transient receptor potential (TRP) channels are a superfamily of non-selective cation permeable channels involved in peripheral sensory signalling. Animal studies have shown that several TRPs are important players in pain modulation. Among them, the TRP melastatin 8 (TRPM8) has elicited more interest for its controversial role in nociception. This channel, expressed by a subpopulation of sensory neurons in dorsal root ganglia (DRG) and trigeminal ganglia (TG), is activated by cold temperatures and cooling agents. In experimental neuropathic pain models, an up-regulation of this receptor in DRG and TG has been observed, suggesting a key role for TRPM8 in the development and maintenance of pain. Consistent with this hypothesis, TRPM8 knockout mice are less responsive to pain stimuli. EXPERIMENTAL APPROACH In this study, the therapeutic potential and efficacy of two novel TRPM8 antagonists, DFL23693 and DFL23448, were tested. KEY RESULTS Two potent and selective TRPM8 antagonists with distinct pharmacokinetic profiles, DFL23693 and DFL23448, have been fully characterized in vitro. In vivo studies in well-established models, namely, the wet-dog shaking test and changes in body temperature, confirmed their ability to block the TRPM8 channel. Finally, TRPM8 blockage resulted in a significant antinociceptive effect in formalin-induced orofacial pain and in chronic constriction injury-induced neuropathic pain, confirming an important role for this channel in pain perception. CONCLUSION AND IMPLICATIONS Our findings, in agreement with previous literature, encourage further studies for a better comprehension of the therapeutic potential of TRPM8 blockers as novel agents for pain management.
Collapse
Affiliation(s)
- Carmen De Caro
- Department of Pharmacy, University of Naples Federico II, Naples, Italy.,Department of Science of Health, School of Medicine and Surgery, University of Catanzaro, Catanzaro, Italy
| | - Roberto Russo
- Department of Pharmacy, University of Naples Federico II, Naples, Italy
| | - Carmen Avagliano
- Department of Pharmacy, University of Naples Federico II, Naples, Italy
| | - Claudia Cristiano
- Department of Pharmacy, University of Naples Federico II, Naples, Italy
| | - Antonio Calignano
- Department of Pharmacy, University of Naples Federico II, Naples, Italy
| | | | | | | | | |
Collapse
|
5
|
Sapio MR, Neubert JK, LaPaglia DM, Maric D, Keller JM, Raithel SJ, Rohrs EL, Anderson EM, Butman JA, Caudle RM, Brown DC, Heiss JD, Mannes AJ, Iadarola MJ. Pain control through selective chemo-axotomy of centrally projecting TRPV1+ sensory neurons. J Clin Invest 2018; 128:1657-1670. [PMID: 29408808 DOI: 10.1172/jci94331] [Citation(s) in RCA: 51] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2017] [Accepted: 02/01/2018] [Indexed: 11/17/2022] Open
Abstract
Agonists of the vanilloid receptor transient vanilloid potential 1 (TRPV1) are emerging as highly efficacious nonopioid analgesics in preclinical studies. These drugs selectively lesion TRPV1+ primary sensory afferents, which are responsible for the transmission of many noxious stimulus modalities. Resiniferatoxin (RTX) is a very potent and selective TRPV1 agonist and is a promising candidate for treating many types of pain. Recent work establishing intrathecal application of RTX for the treatment of pain resulting from advanced cancer has demonstrated profound analgesia in client-owned dogs with osteosarcoma. The present study uses transcriptomics and histochemistry to examine the molecular mechanism of RTX action in rats, in clinical canine subjects, and in 1 human subject with advanced cancer treated for pain using intrathecal RTX. In all 3 species, we observe a strong analgesic action, yet this was accompanied by limited transcriptional alterations at the level of the dorsal root ganglion. Functional and neuroanatomical studies demonstrated that intrathecal RTX largely spares susceptible neuronal perikarya, which remain active peripherally but unable to transmit signals to the spinal cord. The results demonstrate that central chemo-axotomy of the TRPV1+ afferents underlies RTX analgesia and refine the neurobiology underlying effective clinical use of TRPV1 agonists for pain control.
Collapse
Affiliation(s)
- Matthew R Sapio
- Clinical Center, Department of Perioperative Medicine, NIH, Bethesda, Maryland, USA
| | - John K Neubert
- Department of Orthodontics, University of Florida College of Dentistry, Gainesville, Florida, USA
| | - Danielle M LaPaglia
- Clinical Center, Department of Perioperative Medicine, NIH, Bethesda, Maryland, USA
| | - Dragan Maric
- Flow Cytometry Core Facility, NIH, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA
| | - Jason M Keller
- Clinical Center, Department of Perioperative Medicine, NIH, Bethesda, Maryland, USA
| | - Stephen J Raithel
- Clinical Center, Department of Perioperative Medicine, NIH, Bethesda, Maryland, USA
| | - Eric L Rohrs
- Department of Orthodontics, University of Florida College of Dentistry, Gainesville, Florida, USA
| | - Ethan M Anderson
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida, USA
| | - John A Butman
- Clinical Center, Radiology and Imaging Services, NIH, Bethesda, Maryland, USA
| | - Robert M Caudle
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida, USA
| | - Dorothy C Brown
- Veterinary Clinical Investigations Center, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA
| | - John D Heiss
- Surgical Neurology Branch, NIH, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA
| | - Andrew J Mannes
- Clinical Center, Department of Perioperative Medicine, NIH, Bethesda, Maryland, USA
| | - Michael J Iadarola
- Clinical Center, Department of Perioperative Medicine, NIH, Bethesda, Maryland, USA
| |
Collapse
|
6
|
Anderson EM, Reeves T, Kapernaros K, Neubert JK, Caudle RM. Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal. J Pharmacol Exp Ther 2015; 355:496-505. [PMID: 26377910 DOI: 10.1124/jpet.115.227629] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2015] [Accepted: 09/08/2015] [Indexed: 11/22/2022] Open
Abstract
Opioid withdrawal causes a dysphoric state that can lead to complications in pain patients and can propagate use in drug abusers and addicts. Opioid withdrawal changes the activity of neurons in the nucleus accumbens, an area rich in both opioid-binding mu opioid receptors and glutamate-binding NMDA receptors. Because the accumbens is an area important for reward and aversion, plastic changes in this area during withdrawal could alter future behaviors in animals. We discovered an increase in phosphorylation of serine 897 in the NR1 subunit of the NMDA receptor (pNR1) during acute morphine withdrawal. This serine can be phosphorylated by protein kinase A (PKA) and dephosphorylated by calcineurin. We next demonstrated that this increased pNR1 change is associated with an increase in NR1 surface expression. NR1 surface expression and pNR1 levels during acute withdrawal were both reduced by the NMDA receptor antagonist MK-801 (dizocilpine hydrogen maleate) and the PKA inhibitor H-89(N-[2-[[3-(4-bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride hydrate). We also found that pNR1 levels remained high after an extended morphine withdrawal period of 2 months, correlated with reward-seeking behavior for palatable food, and were associated with a decrease in accumbal calcineurin levels. These data suggest that NR1 phosphorylation changes during the acute withdrawal phase can be long lasting and may reflect a permanent change in NMDA receptors in the accumbens. These altered NMDA receptors in the accumbens could play a role in long-lasting behaviors associated with reward and opioid use.
Collapse
Affiliation(s)
- Ethan M Anderson
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida (E.M.A., R.M.C.); Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida (E.M.A., R.M.C.); University of Florida, Gainesville, Florida (T.R., K.K.); and UF College of Dentistry, Department of Orthodontics, Gainesville, Florida (J.K.N.)
| | - Turi Reeves
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida (E.M.A., R.M.C.); Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida (E.M.A., R.M.C.); University of Florida, Gainesville, Florida (T.R., K.K.); and UF College of Dentistry, Department of Orthodontics, Gainesville, Florida (J.K.N.)
| | - Katherine Kapernaros
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida (E.M.A., R.M.C.); Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida (E.M.A., R.M.C.); University of Florida, Gainesville, Florida (T.R., K.K.); and UF College of Dentistry, Department of Orthodontics, Gainesville, Florida (J.K.N.)
| | - John K Neubert
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida (E.M.A., R.M.C.); Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida (E.M.A., R.M.C.); University of Florida, Gainesville, Florida (T.R., K.K.); and UF College of Dentistry, Department of Orthodontics, Gainesville, Florida (J.K.N.)
| | - Robert M Caudle
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida (E.M.A., R.M.C.); Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida (E.M.A., R.M.C.); University of Florida, Gainesville, Florida (T.R., K.K.); and UF College of Dentistry, Department of Orthodontics, Gainesville, Florida (J.K.N.)
| |
Collapse
|
7
|
Olsen R, Andersen H, Møller H, Eskelund P, Arendt-Nielsen L. Somatosensory and vasomotor manifestations of individual and combined stimulation of TRPM8 and TRPA1 using topical L-menthol andtrans-cinnamaldehyde in healthy volunteers. Eur J Pain 2014; 18:1333-42. [DOI: 10.1002/j.1532-2149.2014.494.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/16/2014] [Indexed: 11/09/2022]
Affiliation(s)
- R.V. Olsen
- Center for Sensory-Motor Interaction (SMI); Department of Health Science and Technology; Faculty of Medicine; Aalborg University; Denmark
| | - H.H. Andersen
- Center for Sensory-Motor Interaction (SMI); Department of Health Science and Technology; Faculty of Medicine; Aalborg University; Denmark
| | - H.G. Møller
- Center for Sensory-Motor Interaction (SMI); Department of Health Science and Technology; Faculty of Medicine; Aalborg University; Denmark
| | - P.W. Eskelund
- Center for Sensory-Motor Interaction (SMI); Department of Health Science and Technology; Faculty of Medicine; Aalborg University; Denmark
| | - L. Arendt-Nielsen
- Center for Sensory-Motor Interaction (SMI); Department of Health Science and Technology; Faculty of Medicine; Aalborg University; Denmark
| |
Collapse
|
8
|
Anderson EM, Jenkins AC, Caudle RM, Neubert JK. The effects of a co-application of menthol and capsaicin on nociceptive behaviors of the rat on the operant orofacial pain assessment device. PLoS One 2014; 9:e89137. [PMID: 24558480 PMCID: PMC3928399 DOI: 10.1371/journal.pone.0089137] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2013] [Accepted: 01/20/2014] [Indexed: 01/04/2023] Open
Abstract
Background Transient receptor potential (TRP) cation channels are involved in the perception of hot and cold pain and are targets for pain relief in humans. We hypothesized that agonists of TRPV1 and TRPM8/TRPA1, capsaicin and menthol, would alter nociceptive behaviors in the rat, but their opposite effects on temperature detection would attenuate one another if combined. Methods Rats were tested on the Orofacial Pain Assessment Device (OPAD, Stoelting Co.) at three temperatures within a 17 min behavioral session (33°C, 21°C, 45°C). Results The lick/face ratio (L/F: reward licking events divided by the number of stimulus contacts. Each time there is a licking event a contact is being made.) is a measure of nociception on the OPAD and this was equally reduced at 45°C and 21°C suggesting they are both nociceptive and/or aversive to rats. However, rats consumed (licks) equal amounts at 33°C and 21°C but less at 45°C suggesting that heat is more nociceptive than cold at these temperatures in the orofacial pain model. When menthol and capsaicin were applied alone they both induced nociceptive behaviors like lower L/F ratios and licks. When applied together though, the licks at 21°C were equal to those at 33°C and both were significantly higher than at 45°C. Conclusions This suggests that the cool temperature is less nociceptive when TRPM8/TRPA1 and TRPV1 are co-activated. These results suggest that co-activation of TRP channels can reduce certain nociceptive behaviors. These data demonstrate that the motivational aspects of nociception can be influenced selectively by TRP channel modulation and that certain aspects of pain can be dissociated and therefore targeted selectively in the clinic.
Collapse
Affiliation(s)
- Ethan M. Anderson
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida, United States of America
- Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida, United States of America
- * E-mail:
| | - Alan C. Jenkins
- Department of Orthodontics, University of Florida, Gainesville, Florida, United States of America
| | - Robert M. Caudle
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry, Gainesville, Florida, United States of America
- Department of Neuroscience, University of Florida College of Medicine, McKnight Brain Institute, Gainesville, Florida, United States of America
| | - John K. Neubert
- Department of Orthodontics, University of Florida, Gainesville, Florida, United States of America
| |
Collapse
|
9
|
Cobos EJ, Portillo-Salido E. "Bedside-to-Bench" Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes. Curr Neuropharmacol 2014; 11:560-91. [PMID: 24396334 PMCID: PMC3849784 DOI: 10.2174/1570159x113119990041] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2013] [Revised: 04/05/2013] [Accepted: 05/24/2013] [Indexed: 12/21/2022] Open
Abstract
Despite the myriad promising new targets and candidate analgesics recently identified in preclinical pain studies, little translation to novel pain medications has been generated. The pain phenotype in humans involves complex behavioral alterations, including changes in daily living activities and psychological disturbances. These behavioral changes are not reflected by the outcome measures traditionally used in rodents for preclinical pain testing, which are based on reflexes evoked by sensory stimuli of different types (mechanical, thermal or chemical). These measures do not evaluate the impact of the pain experience on the global behavior or disability of the animals, and therefore only consider a limited aspect of the pain phenotype. The development of relevant new outcomes indicative of pain to increase the validity of animal models of pain has been increasingly pursued over the past few years. The aim has been to translate “bedside-to-bench” outcomes from the human pain phenotype to rodents, in order to complement traditional pain outcomes by providing a closer and more realistic measure of clinical pain in rodents. This review summarizes and discusses the most important nonstandard outcomes for pain assessment in preclinical studies. The advantages and drawbacks of these techniques are considered, and their potential impact on the validation of potential analgesics is evaluated.
Collapse
Affiliation(s)
- Enrique J Cobos
- Department of Pharmacology, School of Medicine, University of Granada, Avenida de Madrid 11, 18012 Granada
| | - Enrique Portillo-Salido
- Drug Discovery and Preclinical Development, Esteve, Avenida Mare de Déu de Montserrat 221, 08041 Barcelona, Spain
| |
Collapse
|
10
|
Murphy NP, Mills RH, Caudle RM, Neubert JK. Operant assays for assessing pain in preclinical rodent models: highlights from an orofacial assay. Curr Top Behav Neurosci 2014; 20:121-45. [PMID: 25103871 DOI: 10.1007/7854_2014_332] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Despite an immense investment of resources, pain remains at epidemic proportions. Given this, there has been an increased effort toward appraising the process by which new painkillers are developed, focusing specifically on why so few analgesics make it from the benchside to the bedside. The use of behavioral assays and animal modeling for the preclinical stages of analgesic development is being reexamined to determine whether they are truly relevant, meaningful, and predictive. Consequently, there is a strengthening consensus that the traditional reflex-based assays upon which several decades of preclinical pain research has been based are inadequate. Thus, investigators have recently turned to the development of new preclinical assays with improved face, content, and predictive validity. In this regard, operant pain assays show considerable promise, as they are more sensitive, present better validity, and, importantly, better encompass the psychological and affective dimensions of pain that trouble human pain sufferers. Here, we briefly compare and contrast reflex assays with operant assays, and we introduce a particular operant orofacial pain assay used in a variety of experiments to emphasize how operant pain assays can be applied to preclinical studies of pain.
Collapse
Affiliation(s)
- Niall P Murphy
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA,
| | | | | | | |
Collapse
|
11
|
Anderson EM, Mills R, Nolan TA, Jenkins AC, Mustafa G, Lloyd C, Caudle RM, Neubert JK. Use of the Operant Orofacial Pain Assessment Device (OPAD) to measure changes in nociceptive behavior. J Vis Exp 2013:e50336. [PMID: 23792907 DOI: 10.3791/50336] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
We present an operant system for the detection of pain in awake, conscious rodents. The Orofacial Pain Assessment Device (OPAD) assesses pain behaviors in a more clinically relevant way by not relying on reflex-based measures of nociception. Food fasted, hairless (or shaved) rodents are placed into a Plexiglas chamber which has two Peltier-based thermodes that can be programmed to any temperature between 7 °C and 60 °C. The rodent is trained to make contact with these in order to access a reward bottle. During a session, a number of behavioral pain outcomes are automatically recorded and saved. These measures include the number of reward bottle activations (licks) and facial contact stimuli (face contacts), but custom measures like the lick/face ratio (total number of licks per session/total number of contacts) can also be created. The stimulus temperature can be set to a single temperature or multiple temperatures within a session. The OPAD is a high-throughput, easy to use operant assay which will lead to better translation of pain research in the future as it includes cortical input instead of relying on spinal reflex-based nociceptive assays.
Collapse
Affiliation(s)
- Ethan M Anderson
- Department of Oral and Maxillofacial Surgery, University of Florida College of Dentistry.
| | | | | | | | | | | | | | | |
Collapse
|